Source: BioPortfolio

Profectus Biosciences: Profectus BioSciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 09052018 Prices from USD $250

SummaryProfectus BioSciences Inc Profectus is a clinicalstage vaccine development company that designs and develops preventive and therapeutic vaccines for infectious diseases and oncolytic vaccines for cancer immunotherapy. The company's products include ...

Read full article »
Profectus Biosciences's Competitors | Profectus Biosciences's News | Profectus Biosciences's Financials
Stay up-to-date with the latest news on Profectus Biosciences
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Jeffrey N. Meshulam's photo - President of Profectus Biosciences

President

Jeffrey N. Meshulam

CEO Approval Rating

87/100

Read more
Stay up-to-date with the latest news on Profectus Biosciences